Interferon Beta for Primary Progressive Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon Beta for Primary Progressive Multiple Sclerosis

Published:2010-01-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rojas Juan Ignacio¹,Romano Marina²,Ciapponi Agustín³,Patrucco Liliana¹,Cristiano Edgardo¹

Affiliation:

1. Hospital Italiano Buenos Aires; Neurology Department; Gascon 450 Buenos Aires Buenos Aires Argentina 1411

2. Hospital Italiano Buenos Aires; Neurology Department; Gascon 450 CABA (Ciudad Autonoma de Buenos Aires) Buenos Aires Argentina 1181

3. Hospital Italiano de Buenos Aires; Family and Preventive Medicine Division; Independencia 1253 PB 'A' Buenos Aires Capital Federal Argentina 1099

Publisher

Wiley

Subject

Pharmacology (medical)

Reference38 articles.

1. Interferon beta-1a in primary progressive MS;Leary;Neurology,2003

2. Leary SM Thompson AJ The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis J Neurol Neurosurg Psychiatry 2004 508 9

3. Miller DH Leary SM Thompson AJ Overview of London trial of intramuscular interferon-beta Ia in primary-progressive multiple sclerosis Multiple sclerosis (Houndmills, Basingstoke, England) 2004 S56 7

4. Overview of European pilot study of interferon B-1b in primary progressive multiple sclerosis;Montalban;Multiple Sclerosis,2004

5. Multicentre randomised double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis;Andersen;Journal of Neurology Neurosurgery and Psychiatry,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost-utility analysis of adding ocrelizumab to the treatment plan for primary progressive multiple sclerosis in Iran;Expert Review of Pharmacoeconomics & Outcomes Research;2024-08-08

2. Multiple Sklerose;Arzneiverordnungs-Report 2023;2023

3. Motor Behavioral Deficits in the Cuprizone Model: Validity of the Rotarod Test Paradigm;International Journal of Molecular Sciences;2022-09-26

4. Literatur;Multiple Sklerose;2022

5. Next-generation version of recombinant human interferon-beta: A molecular dynamic simulation study;Informatics in Medicine Unlocked;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3